Shares of Revelation Biosciences, Inc. (NASDAQ:REVB – Get Free Report) rose 2.8% during mid-day trading on Tuesday . The company traded as high as $4.54 and last traded at $4.40. Approximately 83,958 shares traded hands during trading, a decline of 76% from the average daily volume of 352,171 shares. The stock had previously closed at $4.28.
Revelation Biosciences Trading Up 2.8 %
The company’s 50-day moving average is $5.88 and its 200 day moving average is $11.16. The firm has a market cap of $1.19 million, a PE ratio of -0.02 and a beta of 0.19.
Revelation Biosciences Company Profile
Revelation Biosciences, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease.
Recommended Stories
- Five stocks we like better than Revelation Biosciences
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Overbought Stocks Explained: Should You Trade Them?
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- What is the Hang Seng index?
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Revelation Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revelation Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
